CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)		Total	Common Stock		Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023	[1]		32,820
Beginning balance at Dec. 31, 2023		$ 5,287,282	$ 3	[1]	$ 81,635,120	$ (76,347,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		3,133
Issuance of equity securities, net		38			38
Equity-based compensation expense		77,508			77,508
Net loss		(1,715,290)				(1,715,290)
Ending balance (in shares) at Mar. 31, 2024	[1]		35,953
Ending balance at Mar. 31, 2024		3,649,538	$ 3	[1]	81,712,666	(78,063,131)
Beginning balance (in shares) at Dec. 31, 2023	[1]		32,820
Beginning balance at Dec. 31, 2023		5,287,282	$ 3	[1]	81,635,120	(76,347,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(4,111,844)
Ending balance (in shares) at Sep. 30, 2024	[1]		96,077
Ending balance at Sep. 30, 2024		2,924,583	$ 9	[1]	83,384,259	(80,459,685)
Beginning balance (in shares) at Mar. 31, 2024	[1]		35,953
Beginning balance at Mar. 31, 2024		3,649,538	$ 3	[1]	81,712,666	(78,063,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		6,792
Issuance of equity securities, net		65,080	$ 1	[1]	65,079
Equity-based compensation expense		85,168			85,168
Net loss		(1,424,433)				(1,424,433)
Ending balance (in shares) at Jun. 30, 2024	[1]		42,745
Ending balance at Jun. 30, 2024		2,375,353	$ 4	[1]	81,862,913	(79,487,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		53,332
Issuance of equity securities, net		1,461,342	$ 5	[1]	1,461,337
Equity-based compensation expense		60,009			60,009
Net loss		(972,121)				(972,121)
Ending balance (in shares) at Sep. 30, 2024	[1]		96,077
Ending balance at Sep. 30, 2024		$ 2,924,583	$ 9	[1]	83,384,259	(80,459,685)
Beginning balance (in shares) at Dec. 31, 2024		96,077	96,077	[1]
Beginning balance at Dec. 31, 2024		$ 1,511,695	$ 10	[1]	83,435,303	(81,923,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		42,712
Issuance of equity securities, net		226,170	$ 4	[1]	226,166
Equity-based compensation expense		33,534			33,534
Net loss		(1,709,533)				(1,709,533)
Ending balance (in shares) at Mar. 31, 2025	[1]		138,789
Ending balance at Mar. 31, 2025		$ 61,866	$ 14	[1]	83,695,003	(83,633,151)
Beginning balance (in shares) at Dec. 31, 2024		96,077	96,077	[1]
Beginning balance at Dec. 31, 2024		$ 1,511,695	$ 10	[1]	83,435,303	(81,923,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ (3,540,825)
Ending balance (in shares) at Sep. 30, 2025		944,491	944,491	[1]
Ending balance at Sep. 30, 2025		$ 4,248,065	$ 94	[1]	89,712,414	(85,464,443)
Beginning balance (in shares) at Mar. 31, 2025	[1]		138,789
Beginning balance at Mar. 31, 2025		61,866	$ 14	[1]	83,695,003	(83,633,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		3,030
Issuance of equity securities, net		43,080	$ 0	[1]	43,080
Equity-based compensation expense		23,155			23,155
Net loss		(957,825)				(957,825)
Ending balance (in shares) at Jun. 30, 2025	[1]		141,819
Ending balance at Jun. 30, 2025		(829,724)	$ 14	[1]	83,761,238	(84,590,976)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		802,672
Issuance of equity securities, net		5,928,410	$ 80	[1]	5,928,330
Equity-based compensation expense		22,846			22,846
Net loss		$ (873,467)				(873,467)
Ending balance (in shares) at Sep. 30, 2025		944,491	944,491	[1]
Ending balance at Sep. 30, 2025		$ 4,248,065	$ 94	[1]	$ 89,712,414	$ (85,464,443)

[1] Share and per share amounts have been restated to reflect the 1-for-8 and 1-for-15 reverse stock split effected in June 14, 2024 and August 15, 2025, respectively, on retroactive basis for all periods presented. See accompanying notes to condensed consolidated financial statements.